|
|
||||||||
HOST RESPONSE TO INFECTION |

Departments of Vaccinology and *Bacteriology, National Institute of Public Health, N-0403 Oslo and
Department of Microbiology, Institute of Pharmacy, University of Oslo, Norway
Corresponding author: Dr A. K. H. Berstad (e.mail: aud.herland.berstad{at}folkehelsa.no).
Received 26 March 1999; revised version accepted 2 July 1999.
Abstract
A whole-cell pertussis vaccine, each dose consisting of 250 µg of protein, was given intranasally four times at weekly intervals to six adult volunteers. All vaccinees responded with increases in nasal fluid IgA antibodies to Bordetella pertussis whole-cell antigen. Three vaccinees with high nasal antibody responses also developed increased serum IgA and IgG antibodies to this antigen. Salivary antibody responses to the whole-cell antigen, as well as antibodies in serum and secretions to pertussis toxin (PT) and filamentous haemagglutinin (FHA) were negligible, except for a moderate increase in nasal fluid antibodies to FHA. Unexpectedly, the same vaccinees developed significant rises in nasal and salivary IgA antibodies to meningococcal outer-membrane antigens, whereas corresponding serum IgA and IgG antibodies were unchanged. Thus it appears that mucosal immunisation may induce secretory antibodies with broader specificities than can be found in serum.
This article has been cited by other articles:
![]() |
D. J. Litt, D. Samuel, J. Duncan, A. Harnden, R. C. George, and T. G. Harrison Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J. Med. Microbiol., September 1, 2006; 55(Pt 9): 1223 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cripps, K. Peek, M. Dunkley, K. Vento, J. K. Marjason, M. E. McIntyre, P. Sizer, D. Croft, and L. Sedlak-Weinstein Safety and Immunogenicity of an Oral Inactivated Whole-Cell Pseudomonas aeruginosa Vaccine Administered to Healthy Human Subjects Infect. Immun., February 1, 2006; 74(2): 968 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Huo, R. Sinha, E. A. McNeela, R. Borrow, R. Giemza, C. Cosgrove, P. T. Heath, K. H. G. Mills, R. Rappuoli, G. E. Griffin, et al. Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of the Neisseria meningitidis Serogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan Infect. Immun., December 1, 2005; 73(12): 8256 - 8265. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. G. Mills, C. Cosgrove, E. A. McNeela, A. Sexton, R. Giemza, I. Jabbal-Gill, A. Church, W. Lin, L. Illum, A. Podda, et al. Protective Levels of Diphtheria-Neutralizing Antibody Induced in Healthy Volunteers by Unilateral Priming-Boosting Intranasal Immunization Associated with Restricted Ipsilateral Mucosal Secretory Immunoglobulin A Infect. Immun., February 1, 2003; 71(2): 726 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Janakova, H. Bakke, I. L. Haugen, A. K. H. Berstad, E. A. Hoiby, I. S. Aaberge, and B. Haneberg Influence of Intravenous Anesthesia on Mucosal and Systemic Antibody Responses to Nasal Vaccines Infect. Immun., October 1, 2002; 70(10): 5479 - 5484. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Benton, J. A. Misplon, C.-Y. Lo, R. R. Brutkiewicz, S. A. Prasad, and S. L. Epstein Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or {{gamma}}{{delta}} T Cells J. Immunol., June 15, 2001; 166(12): 7437 - 7445. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |